Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

The prevalence of hyperhomocysteinemia (> 15 µmol/L) was 56.38% in arterial occlusive disease and 54.64% in venous thrombosis. In patients with peripheral vascular occlusive disease, patients ...

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

0.41 ± 1.0 mm late lumen loss at 6 months (angiographic subset, n=10) 4.74 ± 0.86 mm mean minimal lumen diameter at 6 months (angiographic subset, n=10) "In this first patient experience, I ...

Before his retirement, he was diagnosed with Peripheral Arterial Occlusive Disease in his right lower limb.

He was diagnosed with Peripheral Arterial Occlusive Disease in his right lower limb before his retirement. He was assessed to have a 20 per cent disability, added Bar and Bench. He, too ...

Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease ... survivors of prior occlusive events affecting their heart, brain or peripheral arteries.

The EVSS offers a new approach to treating peripheral arterial disease (PAD) by addressing the specific anatomical challenges and complex biomechanics of patients with athero-occlusive disease in ...

An axial image of the chest (Panel A) shows poor opacification of the pulmonary arteries ... change disease or FSGS typically present with abrupt-onset nephrotic syndrome in which peripheral ...